Table 5.
Univariate Hazard Ratios (HR) for distant metastasis in women with first degree family history.
| Characteristic | ≤ 5-year (n= 9) | ≤ 15-year (n= 13) | |||
|---|---|---|---|---|---|
| Estimate | 95% CI | Estimate | 95% CI | Log-rank p-value | |
| Stage | 0.03 | ||||
| II (vs I) | 3.94 | 0.98–15.79 | 3.58 | 1.10–11.63 | |
| Grade | 0.31 | ||||
| High (vs Low) | 2.09 | 7.77 | 1.98 | 0.66–5.88 | |
| Tumor Size | ---1 | --- | 0.12 | ||
| ≤ 1 cm (vs > 1 cm) | 4.59 | 0.60–35.31 | |||
| Nodal Status | 0.07 | ||||
| Pos (vs Neg) | 3.25 | 0.81–13.01 | 2.97 | 0.91–9.66 | |
| Histology | 0.64 | ||||
| IDC (vs LDC, etc) | 1.13 | 0.14–9.06 | 1.78 | 0.23–13.71 | |
| Estrogen Receptor | 0.003 | ||||
| Neg (vs Pos) | 21.28 | 2.66–166.7 | 4.54 | 1.47–13.89 | |
| Progesterone Receptor | 0.003 | ||||
| Neg (vs Pos) | 20.41 | 2.55–166.7 | 4.39 | 1.43–13.51 | |
| HER-2 Neu | 0.18 | ||||
| Neg (vs Pos) | 2.43 | 0.30–19.2 | 3.45 | 0.44–27.0 | |
| EZH2 Expression | 0.05 | ||||
| High (vs Low) | 7.99 | 1.00–63.9 | 3.57 | 0.98–12.99 | |
1
Calculation was not feasible due to empty cell.